SCHEMBL20147346

SCHEMBL20147346

CC(C)N1CCC(C)(CN2CCN(C(=O)OC(C)(C)C)CC2C)CC1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.39
SETD7 Q8WTS6 1/20 0.36
RET P07949 1/20 0.35
NR1H2 P55055 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
GPR119 Q8TDV5 6/20 0.34
EPHX2 P34913 1/20 0.34
HSD11B1 P28845 1/20 0.33
NPC1 O15118 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158745 0.82 RET (0.50) HRH3SETD7RETALDH1A1MAPT
SCHEMBL20147374 0.81 HRH3 (0.41) HRH3ALDH1A1MAPTEPHX2NPC1
SCHEMBL20147320 0.77 SETD7 (0.36) HRH3SETD7RETNR1H2GPR119
SCHEMBL28720777 0.76 ALDH1A1 (0.41) SETD7NR1H2ALDH1A1MAPTMEN1
SCHEMBL28721564 0.76 ALDH1A1 (0.41) SETD7NR1H2ALDH1A1MAPTMEN1
SCHEMBL28720780 0.76 ALDH1A1 (0.41) SETD7NR1H2ALDH1A1MAPTMEN1
SCHEMBL17477191 0.75 NR1H2 (0.44) SETD7NR1H2ALDH1A1MAPTMEN1
SCHEMBL17477192 0.75 NR1H2 (0.44) SETD7NR1H2ALDH1A1MAPTMEN1
SCHEMBL13442980 0.75 NR1H2 (0.44) SETD7NR1H2ALDH1A1MAPTMEN1
SCHEMBL20068903 0.74 SETD7 (0.37) SETD7NR1H2ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180133207-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180133207-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, BRAF, RAF1 HRH3 1000/4885SETD7 1088/4885RET 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.